Our experiments showed a remarkable delay in AE leukemia growth upon induction of Zeb2 interference with 4-OHT treatment, confirming that Zeb2 is a relevant target also in the t(8;21) AML subtype. This evidence concerns the gene ZEB2 and acute myeloid leukemia.